Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis
Clinical trial NCT01127893 · TERMINATED
Trial details
- NCT number
- NCT01127893
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-15
- Primary completion
- 2010-09-29
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.